Archive

Poster Session at ECC 2013 – Circulating tumour cell counts in advanced and metastatic colorectal cancer by immunomagnetic labelling: Results reflect the reality?

Written by Lorraine Carolan | 2 Dec 2013

Solange M Sanches et al, AC Camargo Cancer Center, São Paulo, Brazil.

Poster Session at ECC 2013 – Younger patients at high risk

Written by Lorraine Carolan | 2 Dec 2013

Discussion of the abstract by Dr Christopher Lieu, MD, Assistant professor at the University of Colorado. Younger patients with colorectal cancer that has spread (metastasised) to other parts… read more.

Poster Session at ECC 2013 – How to endure life during treatment for colorectal cancer

Written by Lorraine Carolan | 29 Nov 2013

Birgitte Pedersen et al, Vejle Hospital, Denmark. Patients with colorectal cancer (CRC) face huge challenges in their everyday lives as a result of their condition and treatments.

Poster Session at ECC 2013 – Screening in colorectal cancer works

Written by Lorraine Carolan | 29 Nov 2013

Discussion of the abstract by Professor Philippe Autier, Vice President, Population Studies, at the International Prevention Research Institute, Lyon, France.

Poster Session at ECC 2013 – Biology of the tumour key to treatment

Written by Lorraine Carolan | 28 Nov 2013

Discussion of the abstract by Dr Zoran Gatalica, Adjunct Professor of Pathology at Creighton University School of Medicine .

Poster Session at ECCO 2013 – Aspirin unmasks tumour cells

Written by Lorraine Carolan | 28 Nov 2013

Oral discussion of abstract by Professor Naredi, Sahlgrenska University Hospital, Gothenburg, Sweden. Researchers believe they have discovered how aspirin improves survival in patients diagnosed with colon cancer.

ECC 2013 Report: Joint ECCO/BDA Special Session: Accelerating patient access to innovative drugs in Europe

Written by Lorraine Carolan | 27 Nov 2013

by Peter Mas Mollinedo – Improvements in diagnostics and medical treatments mean the number of patients living with cancer is increasing around the world. The World Health Organization… read more.

ECC 2013 Report – Role of aggressive surgery for peritoneal metastases

Written by Lorraine Carolan | 27 Nov 2013

by Peter Mas Mollinedo reporting on the presentation by Dominique Elias, Gustave-Roussy Institute, Paris, France. – Aggressive complete cytoreductive surgery (CCRS) in combination with hyperthermic intraperitoneal chemotherapy (HIPEC)… read more.

ECC 2013 Report: Gastrointestinal malignancies – colorectal cancer

Written by Lorraine Carolan | 27 Nov 2013

LM Wiltink, Leiden University Medical Center, the Netherlands; Hans-Joachim Schmoll, Martin Luther University Halle – Wittenberg, Germany. A unique 14-year follow-up study from the universities of Leiden in… read more.

Survival in advanced pancreatic cancer significantly improved with nab-paclitaxel

Written by Bruce Sylvester | 15 Nov 2013

by Bruce Sylvester – taken from the NEJM (New England Journal of Medicine) – Addition of nab-paclitaxel to gemcitabine for treatment of advanced pancreatic cancer has resulted in… read more.

ECC 2013: Late Breaking Clinical Trials: ASPECCT

Written by Lorraine Carolan | 15 Nov 2013

by Esther Drain reporting on the presentation by Dr Timothy Price – A randomized, multicenter, open-label, phase 3 study of panitumumab (pmab) vs cetuximab (cmab) for previously treated… read more.